Empagliflozin; linagliptin - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for empagliflozin; linagliptin and what is the scope of patent protection?
Empagliflozin; linagliptin is the generic ingredient in two branded drugs marketed by Boehringer Ingelheim and is included in two NDAs. There are twenty-one patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.
Empagliflozin; linagliptin has six hundred and six patent family members in forty-eight countries.
One supplier is listed for this compound. There are three tentative approvals for this compound.